BARD1 and hepatocellular carcinoma: Silencing of BARD1 led to the suppression of the proliferation, invasion, and migration of HCC cells by decreasing the levels of Akt, mTOR, and MMP- 9, as well as inhibiting the phosphorylation of Akt and mTOR [19].